Olanzapine News and Research

RSS
Olanzapine (trade names Zyprexa, Zyprexa Zydis, Zalasta, Zolafren, Olzapin, Rexapin or in combination with fluoxetine Symbyax) is an atypical antipsychotic, approved by the FDA for the treatment of schizophrenia and bipolar disorder.
Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Drug used to treat schizophrenia and other psychotic disorders appears effective at treating Alzheimer’s disease

Researchers find next generation of medications to help schizophrenics

Researchers find next generation of medications to help schizophrenics

FDA has approved Zyprexa, injectable anti-psychotic drug

FDA has approved Zyprexa, injectable anti-psychotic drug